Hillsdale Investment Management Inc. Voyager Therapeutics, Inc. Transaction History

Hillsdale Investment Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$7.55 - $11.25 $50,887 - $75,825	6,740 Added 1.87%	367,590 $2.85 Million
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $2.5 Million - $5.05 Million	360,850 New	360,850 $4.13 Million
Q4 2022 Feb 13, 2023	SELL	$4.94 - $6.61 $24,700 - $33,050	-5,000 Reduced 5.68%	82,967 $506,000
Q3 2022 Nov 10, 2022	BUY	$5.57 - $7.47 $380,431 - $510,201	68,300 Added 347.28%	87,967 $521,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $94,794 - $198,440	19,667 New	19,667 $116,000
Q4 2019 Feb 12, 2020	SELL	$12.82 - $16.85 $474,340 - $623,450	-37,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.31 - $28.29 $603,470 - $1.05 Million	37,000 New	37,000 $637,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.